Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
02/08/1996 | WO1996003494A1 Method of control of microorganism growth process |
02/08/1996 | WO1996003438A1 Antibodies which activate an erythropoietin receptor |
02/08/1996 | WO1996003415A1 Human potassium channel 1 and 2 proteins |
02/08/1996 | WO1996003160A1 Fibrin-cell suspension for construction of new tissue |
02/08/1996 | WO1996003151A2 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
02/08/1996 | WO1996003094A1 Membrane for regenerating body tissues and use of said membrane as a wound covering and substitute skin |
02/08/1996 | WO1996003051A1 Production of collagen in the milk of transgenic mammals |
02/08/1996 | WO1996003033A2 Use of a commiphora mukul extract as a pigmenting agent |
02/08/1996 | WO1995022611A3 Methods and compositions for stimulating bone cells |
02/08/1996 | CA2196052A1 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
02/08/1996 | CA2196051A1 Surface expression of enzyme in gene directed prodrug therapy |
02/08/1996 | CA2195868A1 Antibodies which activate an erythropoietin receptor |
02/08/1996 | CA2195867A1 Membrane for regenerating body tissues and use of said membrane as a wound covering and substitute skin |
02/08/1996 | CA2195786A1 Isoamylase gene from flaviobacterium sp., compositions containing it andmethods using it |
02/08/1996 | CA2195678A1 Bradykinin b2 receptor modified transgenic non-human animals |
02/08/1996 | CA2195673A1 Use of a commiphora mukul extract as a pigmenting agent |
02/08/1996 | CA2195629A1 Src sh3 binding peptides and methods of isolating and using same |
02/08/1996 | CA2195309A1 Methods for the preparation of retroviral particles and cell lines deficient in the alpha-galactosyl epitope |
02/07/1996 | EP0695804A2 Recombinant enzyme for converting maltose into trehalose |
02/07/1996 | EP0695361A1 Expression of heterologous genes according to a targeted expression profile |
02/07/1996 | EP0695357A1 Mammal cell lines and method of obtaining glycoproteins |
02/07/1996 | EP0695351A1 Isolation, selection and propagation of animal transgenic stem cells |
02/07/1996 | EP0695347A1 Methods and materials for treatment of individuals infected with intracellular infectious agents |
02/07/1996 | EP0695346A1 Human erythroid progenitor cell population |
02/07/1996 | EP0695311A1 Cellulose binding domain |
02/07/1996 | EP0695189A1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
02/07/1996 | EP0652943A4 Hematopoietic facilitatory cells and their uses. |
02/07/1996 | EP0420848B1 Carcinoma-associated antigens, and antibodies which recognize these antigens |
02/07/1996 | CN1116238A Method for cultiating tomato with function of anti virus of mosaic of cucumber by gene engineering |
02/06/1996 | US5489743 Transgenic animal models for thrombocytopenia |
02/06/1996 | US5489527 Translation of m-RNA |
02/06/1996 | US5489525 Monoclonal antibodies to prostate cells |
02/06/1996 | US5489520 Process of producing fertile transgenic zea mays plants and progeny comprising a gene encoding phosphinothricin acetyl transferase |
02/06/1996 | US5489519 Multidrug resistance protein |
02/06/1996 | US5489516 Hybridoma and monoclonal antibody specific for human stem cell factor receptor and methods of use of the monoclonal antibody for detection of stem cell factor receptors |
02/06/1996 | US5489508 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
02/06/1996 | US5489386 Density gradient medium for the separation of cells |
02/06/1996 | US5489261 Hydrogels capable of supporting cell growth |
02/06/1996 | CA1338032C Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas |
02/01/1996 | WO1996002662A1 Human marrow stromal cell lines which sustain hematopoiesis |
02/01/1996 | WO1996002656A1 Taxane production in haploid-derived cell cultures |
02/01/1996 | WO1996002652A2 β-KETOACYL ACP REDUCTASE GENES FROM BRASSICA NAPUS |
02/01/1996 | WO1996002649A1 Modified plant viruses as vectors of heterologous peptides |
02/01/1996 | WO1996002648A1 Lkp pilin structural genes and operon of nontypable haemophilus influenzae |
02/01/1996 | WO1996002646A2 Growth control for cells encapsulated within bioartificial organs |
02/01/1996 | WO1996002645A2 Htk ligand |
02/01/1996 | WO1996002643A1 Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family |
02/01/1996 | WO1996002640A1 Alpha-lactalbumin gene constructs |
02/01/1996 | WO1996002561A1 Interaction trap systems for detecting protein interactions |
02/01/1996 | WO1996002276A2 Novel polymer gel networks and methods of use |
02/01/1996 | WO1996002273A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
02/01/1996 | WO1995034668A3 The cytoplasmic inhibition of gene expression |
02/01/1996 | WO1995013385A3 Thrombin mutants |
02/01/1996 | DE19527560A1 Storage-stable, virus-free hop root-stock prodn. |
02/01/1996 | CA2694296A1 Growth control for cells encapsulated within bioartificial organs |
02/01/1996 | CA2195564A1 .beta.-ketoacyl acp reductase genes from brassica napus |
02/01/1996 | CA2195454A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
02/01/1996 | CA2195335A1 Human marrow stromal cell lines which sustain hematopoiesis |
02/01/1996 | CA2194955A1 Htk ligand |
02/01/1996 | CA2194701A1 Taxane production in haploid-derived cell cultures |
02/01/1996 | CA2193513A1 Alpha-lactalbumin gene constructs |
01/31/1996 | EP0694072A1 Transposition assembly for gene transfer in eukaryotes |
01/31/1996 | EP0694070A1 Recombinant alphavirus vectors |
01/31/1996 | EP0694069A1 Variant insulin-like growth factor i receptor subunits and methods for use thereof |
01/31/1996 | EP0694068A1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs |
01/31/1996 | EP0694062A1 New bacillus thuringiensis strains and their insecticidal proteins |
01/31/1996 | EP0694042A1 Inhibitor of vascular endothelial cell growth factor |
01/31/1996 | EP0693940A1 Hybrid genes for use in the production of t h?-independent cytotoxic t cells |
01/31/1996 | EP0693874A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
01/31/1996 | EP0590132A4 -i(in vitro)-derived human neutrophil precursor cells |
01/31/1996 | EP0502928B1 Methods of detecting bone resorption in vivo |
01/31/1996 | CN1115990A Gene that identifies sterile plant cytoplasm and process for preparing hybrid plant by using the same |
01/30/1996 | US5488099 Multifunctional chimeric neurotrophic factors |
01/30/1996 | US5488035 Peptide with inhibitory activity towards plant pathogenic fungi |
01/30/1996 | US5487983 Expression systems for making single-chain monellin analogs |
01/30/1996 | US5487974 Contact blood samples and determine proliferation of cytolytic lymphocytes and lysis of cells presenting said complexes |
01/30/1996 | US5487891 Human anti-RH(D) monoclonal antibodies reagents and hybridomas and methods of RH typing using anti-RH(D) monoclonal antibodies and reagents |
01/30/1996 | US5487889 Envelope encloses cells that secrete wound healing growth factors; genetic engineering |
01/30/1996 | US5487739 Implantable therapy systems and methods |
01/30/1996 | CA1338010C Heat shock promoter and gene |
01/25/1996 | WO1996001904A1 Production of oligosaccharides in transgenic plants |
01/25/1996 | WO1996001902A1 Adenovirus comprising a gene coding for an no synthase |
01/25/1996 | WO1996001899A1 METHOD FOR IDENTIFYING NUCLEIC ACIDS ENCODING c-fos PROMOTER ACTIVATING PROTEINS |
01/25/1996 | WO1996001898A1 Human kappa opioid receptor, nucleic acids and uses thereof |
01/25/1996 | WO1996001896A1 Connective tissue growth factor-2 |
01/25/1996 | WO1996001895A1 Dna coding for phosphoenolpyruvate carboxykinase, recombinant vector containing the same, and transgenic plant |
01/25/1996 | WO1996001893A1 Recombinant kat enzyme and process for its preparation |
01/25/1996 | WO1996001891A1 Method for generating a population of cells having a high surface density of a mhc molecule-associated specific exogenous peptide, and cell population |
01/25/1996 | WO1996001847A1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown |
01/25/1996 | WO1996001845A1 Growth differentiation factor-11 |
01/25/1996 | WO1996001835A1 Mammalian telomerase |
01/25/1996 | WO1996001614A2 Rna component of telomerase |
01/25/1996 | WO1996001557A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
01/25/1996 | WO1996001555A1 ENDO-1,4-β-GLUCANASE GENES AND THEIR USE IN PLANTS |
01/25/1996 | CA2194768A1 Human kappa opioid receptor, nucleic acids and uses thereof |
01/25/1996 | CA2194451A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
01/25/1996 | CA2194447A1 Recombinant kat enzyme and process for its preparation |
01/25/1996 | CA2194361A1 Method for identifying nucleic acids encoding c-fos promoter activating proteins |
01/25/1996 | CA2193263A1 Adenovirus comprising a gene coding for an no synthase |
01/25/1996 | CA2171470A1 Dna encoding phosphoenolpyruvate caboxykinase, recombinant vector and transformed plant containing the same |